Related Experiment Video
Updated: May 23, 2026

A Reporter Based Cellular Assay for Monitoring Splicing Efficiency
Published on: September 15, 2021
Antisense-mediated exon skipping to reframe transcripts
Sandrina Turczynski1, Matthias Titeux, Nathalie Pironon
1INSERM, U781, Paris, France.
Abstract:
Numerous genetic disorders are caused by loss-of-function mutations that disrupt the open reading frame of the gene either by nonsense or by frameshift (insertion, deletion, indel, or splicing) mutations. Most of the time, the result is the absence of functional protein synthesis due to mRNA degradation by nonsense-mediated mRNA decay, or rapid degradation of a truncated protein. Antisense-based splicing modulation is a powerful tool that has the potential to treat genetic disorders by restoring the open reading frame through selective removal of the mutated exon, or by restoring correct splicing.We have developed this approach for a severe genetic skin disorder, recessive dystrophic epidermolysis bullosa, caused by mutations in the COL7A1 gene encoding type VII collagen. This gene is particularly suited for exon-skipping approaches due to its unique genomic structure. It is composed of 118 exons, 83 of which are in frame. Moreover, these exons encode a single repetitive collagenous domain.Using this gene as an example, we describe general methods that demonstrate the feasibility and efficacy of the antisense-mediated exon-skipping strategy to reframe transcripts.
Insights
Antisense-based splicing modulation can restore gene function in genetic disorders. This study demonstrates its efficacy in treating recessive dystrophic epidermolysis bullosa by correcting COL7A1 gene transcripts.
Area of Science:
- Genetics
- Molecular Biology
- Biotechnology
Background:
- Genetic disorders often result from loss-of-function mutations disrupting gene open reading frames.
- Nonsense-mediated mRNA decay or truncated protein degradation typically prevents functional protein synthesis.
Purpose of the Study:
- To develop and demonstrate the feasibility of antisense-based splicing modulation for treating genetic disorders.
- To restore the open reading frame (ORF) and enable functional protein synthesis.
Main Methods:
- Utilized antisense-based splicing modulation to selectively remove mutated exons.
- Applied the strategy to the COL7A1 gene, encoding type VII collagen, for recessive dystrophic epidermolysis bullosa.
- Leveraged the unique genomic structure of COL7A1 (118 exons, 83 in-frame) for exon-skipping.
Main Results:
- Demonstrated the feasibility and efficacy of antisense-mediated exon-skipping.
- Showcased the potential to reframe transcripts and restore protein synthesis.
- Successfully applied the method to a severe genetic skin disorder.
Conclusions:
- Antisense-based splicing modulation is a promising therapeutic strategy for genetic disorders.
- Exon-skipping offers a viable approach to correct mutations and restore protein function.
- The COL7A1 gene serves as a relevant model for this therapeutic strategy.
Related Concept Videos
RNA Splicing
RNA Splicing
Alternative RNA Splicing
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
Alternative RNA Splicing
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
Exon Recombination
Exon shuffling follows “splice frame rules.” Each exon has three reading...
Nonsense-mediated mRNA Decay
Usually, Upf3 binds to an Exon Junction Complex (EJC) at mRNA splice sites. If a ribosome fully translates the mRNA,...

